Nasdaq

AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food and Drug Administration for Treatment of Vitiligo

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)-- AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet ...
Yahoo Finance

Avita Medical Secures US FDA Approval to Modify ReCell(R) Clinical Burns Trial

The US FDA has approved Avita's request for expanded use of ReCell® and broadened eligibility criteria for study participants The broadened eligibility criteria are anticipated to resolve ongoing ...
Business Wire

AVITA Medical Announces RECELL® Data Demonstrating Statistically Significant Reduction in Donor Skin Requirements and Pain, Increased Patient Satisfaction and Improved Donor ...

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH) (OTCQX: AVMXY) announced today that results from a pivotal clinical trial demonstrating the effectiveness and ...
manilatimes

AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL

VALENCIA, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today highlighted ...
Business Wire

Avita Medical Announces Submission of U.S. FDA Premarket Approval (PMA) Application for the ReCell® Device for Treatment of Burn Injuries

VALENCIA, Calif. & PERTH, Australia & LONDON--(BUSINESS WIRE)--Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, ...
Monthly Prescribing Reference

RECELL System Approved to Treat Severe Burns

At Week 8 post-treatment, 92% of the burn sites treated with RECELL System achieved complete healing vs 85% of sites treated with standard-of-care, demonstrating non-inferiority. AVITA Medical ...
FierceBiotech

Avita snags $8M from BARDA to aid in PMA filing for ReCell

Avita Medical will gain an additional $8 million to support its plans for U.S. market approval and launch of ReCell, a device that creates Regenerative Epithelial Suspension (RES) to aid in the ...
Medindia

Avita Medical's ReCell Spray-On Skin Works Better Than Skin Grafting

The ReCell kit for the harvesting and application of autologous skin cells worked better than skin grafting in a pilot study, Avita Medical has announced. The ReCell kit for the harvesting and ...
Nasdaq

RECELL® System Data to be Presented at the Controversies and Conversations in Laser & Cosmetic Surgery Annual Meeting

VALENCIA, Calif. and MELBOURNE, Australia, Aug. 17, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a ...
Yahoo Finance

AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of Use

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Finanznachrichten

Avita Medical Announces Submission of U.S. FDA Premarket Approval (PMA) Application for the ReCell Device for Treatment of Burn Injuries

Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that it has submitted to the Food Drug Administration ...